SODIUM IODIDE (131I) SOLUTION
Google image searchProduct monograph
Active ingredient
sodium iodide 131 i, 37 GBQ/ML
DIN: 02439905
Dosage form(s): SOLUTION
Route(s) of administration: ORAL
Schedule: Schedule C
Company: ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.
Date: 03-AUG-2018
ATC:
- V10 — THERAPEUTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V10X — OTHER THERAPEUTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD)
- V10XA — Iodine (131I) compounds (ATC, ATC/DDD)
- V10XA01 — SODIUM IODIDE 131 I (ATC/DDD)